Ads
related to: Novavax
Search results
Better Buy: Inovio Pharmaceuticals vs. Novavax
The Motley Fool via AOL· 3 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Why Vaccine Stocks Rallied This Week
The Motley Fool via AOL· 1 day agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 3 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 5 days agoNovavax, Inc.’s recently made public that its President, R&D Dubovsky Filip unloaded Company’s shares for reported $0.66 million on May 14 ’24. In the deal valued at $13.90 ...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 2 days agoLoading... Loading... Deep-pocketed investors have adopted a bearish approach towards Novavax NVAX , and it's something market players shouldn't ignore. Our tracking of public ...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 1 day agoShares of vaccine stocks Moderna (MRNA 1.58%), Novavax (NVAX 2.31%), and BioNTech SE (BNTX -2.07%)...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via AOL· 5 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Shah Capital ends campaign against Novavax board after Sanofi deal By Reuters
Investing.com· 5 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 6 days agoVaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 5 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...